Enterprise Solutions

1. Nanomedicine: Where Few CDMOs Dare To Go 11/4/2026

   Custom nanoparticle development and cGMP manufacturing for medical applications are specialized work that few contract partners attempt, spanning the path from preclinical studies to commercialization.

2. We Know NANO: Our Expertise 11/4/2026

   A single partner carries nanomedicine programs from screening to clinical supply across lipid, polymeric, and metal-based particles, with precursor manufacturing newly added to the lineup.

3. Small-Scale Studies To Support Preclinical Viral Vector Development 11/3/2026

   Small-scale AAV and LV batches let programs test constructs and generate IND-enabling data on guaranteed timelines, with a defined route from feasibility work toward eventual GMP production.

4. Complex ADC Development. Simplified. One Coordinated European Platform 11/2/2026

   Successful targeted oncology programs combine biological engineering, potent compound synthesis, and efficient manufacturing to reduce complexity and speed clinical progress.

5. Your Partner In Biosimilar Success 11/2/2026

   Bringing biosimilars to market efficiently requires strong cell line development, analytical characterization, and scalable manufacturing backed by regulatory expertise.

6. Complex Biologics: From Gene To Market 11/2/2026

   Accelerating biologics from development to commercialization requires integrated expertise, optimized cell lines, flexible manufacturing, and regulatory rigor to speed clinical and market success.

7. Advancing Medicines That Matter - CDMO Capabilities Overview 10/31/2026

   North American biologics manufacturing supports programs from drug substance through fill/finish, device assembly, and cold-chain logistics, backed by 10+ years of regulatory inspections.

8. Guaranteed Tech Transfer And Process Development – Or Your Money Back 10/28/2026

   De-risk biotech development with guaranteed tech transfer and process support. Safeguard your investment from cell line development through protein optimization.

9. Nunc Cell Factory Systems: For Consistent Cell Culture Performance 10/26/2026

   Scaling adherent cell culture from flasks to multilayer systems depends on surface consistency, aseptic connections, and more. See how ultrasonic welding and retention hardware shape that path.

10. Cell Therapy CDMO Services: Cell Therapies. Delivered. 10/26/2026

    Combining cell therapy development, manufacturing, and release testing with one partner reduces handoffs, streamlines logistics, and speeds therapies to patients.